Literature DB >> 10449457

Somatic serogroups, capsular types, and species of fecal Klebsiella in patients with ankylosing spondylitis.

P Toivanen1, D S Hansen, F Mestre, L Lehtonen, J Vaahtovuo, M Vehma, T Möttönen, R Saario, R Luukkainen, M Nissilä.   

Abstract

The purpose of the present study was to find out whether patients with ankylosing spondylitis (AS) carry fecal Klebsiella strains that belong to serotypes or species specific for AS. Somatic serotypes (O groups), capsular (K) serotypes, and biochemically identified species were determined for fecal klebsiellae isolated from 187 AS patients and 195 control patients. The controls were patients with fibromyalgia or rheumatoid arthritis. The 638 isolates of Klebsiella that were obtained represented 161 strains; 81 from AS patients and 80 from the controls. The average number of Klebsiella strains per patient was 1.7 for the AS group and 1.5 for the control group. The most common O group was O1, which was observed for isolates from 23 of 187 AS patients and 24 of 195 control patients. Next in frequency was group O2, which was observed for isolates from 17 AS patients and 15 control patients. Regarding the K serotypes, 59 different types were identified, revealing a heterogeneous representation of Klebsiella strains, without a predominance of any serotype. By biochemical identification, Klebsiella pneumoniae was the most frequently occurring species, being found in 45 AS patients and 45 control patients. Next in the frequency was K. oxytoca, which was observed in 26 AS patients and in 29 control patients. K. planticola and K. terrigena occurred in only a minority of patients. Altogether, when analyzed either separately or simultaneously according to O groups, K serotypes, and biochemically identified species, no evidence of the existence of AS-specific Klebsiella strains was obtained. These findings do not indicate participation of Klebsiella in the etiopathogenesis of AS.

Entities:  

Mesh:

Year:  1999        PMID: 10449457      PMCID: PMC85385     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  Antibodies to Klebsiella pneumoniae in Dutch patients with ankylosing spondylitis and acute anterior uveitis and to Proteus mirabilis in rheumatoid arthritis.

Authors:  S H Blankenberg-Sprenkels; M Fielder; T E Feltkamp; H Tiwana; C Wilson; A Ebringer
Journal:  J Rheumatol       Date:  1998-04       Impact factor: 4.666

2.  Seroepidemiology of Klebsiella bacteremic isolates and implications for vaccine development.

Authors:  S J Cryz; P M Mortimer; V Mansfield; R Germanier
Journal:  J Clin Microbiol       Date:  1986-04       Impact factor: 5.948

3.  Serum antibodies to Klebsiella capsular polysaccharides in ankylosing spondylitis.

Authors:  H Sahly; R Podschun; R Sass; B Bröker; J Kekow; W L Gross; U Ullmann
Journal:  Arthritis Rheum       Date:  1994-05

4.  Lectinophagocytosis of encapsulated Klebsiella pneumoniae mediated by surface lectins of guinea pig alveolar macrophages and human monocyte-derived macrophages.

Authors:  A Athamna; I Ofek; Y Keisari; S Markowitz; G G Dutton; N Sharon
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

Review 5.  Ankylosing spondylitis is not caused by Klebsiella.

Authors:  A S Russell; M E Suarez Almazor
Journal:  Rheum Dis Clin North Am       Date:  1992-02       Impact factor: 2.670

Review 6.  Ankylosing spondylitis is caused by Klebsiella. Evidence from immunogenetic, microbiologic, and serologic studies.

Authors:  A Ebringer
Journal:  Rheum Dis Clin North Am       Date:  1992-02       Impact factor: 2.670

7.  Epidemiology of Klebsiella bacteraemia: a case control study using Escherichia coli bacteraemia as control.

Authors:  D S Hansen; A Gottschau; H J Kolmos
Journal:  J Hosp Infect       Date:  1998-02       Impact factor: 3.926

8.  Klebsiella pneumoniae lipopolysaccharide O typing: revision of prototype strains and O-group distribution among clinical isolates from different sources and countries.

Authors:  D S Hansen; F Mestre; S Alberti; S Hernández-Allés; D Alvarez; A Doménech-Sánchez; J Gil; S Merino; J M Tomás; V J Benedí
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

9.  Immunoelectrophoretic patterns of extracts from Escherichia coli O antigen test strains O1 to O157 examinations in homologous OK sera. Further comments on the classification of Escherichia K antigens.

Authors:  F Orskov; I Orskov
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1972

10.  Yersinia antigens in synovial-fluid cells from patients with reactive arthritis.

Authors:  K Granfors; S Jalkanen; R von Essen; R Lahesmaa-Rantala; O Isomäki; K Pekkola-Heino; R Merilahti-Palo; R Saario; H Isomäki; A Toivanen
Journal:  N Engl J Med       Date:  1989-01-26       Impact factor: 91.245

View more
  6 in total

1.  Variants of the Klebsiella pneumoniae OKP chromosomal beta-lactamase are divided into two main groups, OKP-A and OKP-B.

Authors:  Cindy Fevre; Virginie Passet; François-Xavier Weill; Patrick A D Grimont; Sylvain Brisse
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

2.  Increased serum resistance in Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases.

Authors:  H Sahly; H Aucken; V J Benedí; C Forestier; V Fussing; D S Hansen; I Ofek; R Podschun; D Sirot; J M Tomás; D Sandvang; U Ullmann
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

3.  Impairment of respiratory burst in polymorphonuclear leukocytes by extended-spectrum beta-lactamase-producing strains of Klebsiella pneumoniae.

Authors:  H Sahly; H Aucken; V J Benedi; C Forestier; V Fussing; D S Hansen; I Ofek; R Podschun; D Sirot; D Sandvang; J M Tomás; U Ullmann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-12-02       Impact factor: 3.267

4.  wzi Gene sequencing, a rapid method for determination of capsular type for Klebsiella strains.

Authors:  Sylvain Brisse; Virginie Passet; Anita Björk Haugaard; Anamaria Babosan; Najiby Kassis-Chikhani; Carsten Struve; Dominique Decré
Journal:  J Clin Microbiol       Date:  2013-10-02       Impact factor: 5.948

5.  Cancer incidence among patients with ankylosing spondylitis in Sweden 1965-95: a population based cohort study.

Authors:  N Feltelius; A Ekbom; P Blomqvist
Journal:  Ann Rheum Dis       Date:  2003-12       Impact factor: 19.103

6.  Surgical orodental implications in ankylosing spondylitis.

Authors:  Mohammad Mehdizadeh; Bejeh Mir A Poorsattar
Journal:  Dent Res J (Isfahan)       Date:  2012-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.